EpiPen price hikes cost DOD millions

Mylan’s price increases for EpiPens have cost the U.S. Department of Defense millions of dollars since 2008 as the agency covered more prescriptions at near retail prices, according to government data reported by Reuters.

Advertisement

Pentagon spending on EpiPens rose from $9 million in 2008 to $57 million over the past year, an increase attributable to increasing volume and price hikes for the lifesaving allergy shot. The Pentagon gets a government discount on EpiPens dispensed at military treatment facilities and by mail order. However, nearly half of its spending was at retail pharmacies where it paid nearly three times more than its discounted rate: an average of $509 for EpiPen and $528 for EpiPen Jr. two-packs, according to the report.

However, the DOD’s spending on EpiPens might come down in the future. Both the Pentagon and Mylan told Reuters they are discussing a military discount via rebates for EpiPens filled at retail pharmacies.

More articles on supply chain:
Kits for care: How global sourcing helped Northside Hospital boost patient comfort
FDA approves Medtronic’s larger aortic valve replacement system
Indiana Blood Center in desperate need of donations

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.